Targeted fat metabolism
Stimulates fat breakdown and inhibits fat storage without systemic growth hormone effects.


The fat-burning fragment of growth hormone for targeted weight management.
Starting at
Includes doctor review & treatment plan
All plans include doctor review, personalized treatment plan, and 24/7 provider access.
No. AOD-9604 is a small fragment of the growth hormone molecule (amino acids 177-191) that only replicates the fat-burning effects of HGH. It does not have growth-promoting, blood sugar, or IGF-1 effects.
No. Clinical studies have confirmed that AOD-9604 does not affect glucose metabolism or insulin sensitivity, making it distinct from full-length growth hormone.
Weight management results with AOD-9604 typically become apparent over 8-12 weeks of consistent use, combined with appropriate diet and exercise. Early changes in body composition may be noticed sooner.
Each plan may include several of the following formulations.
Stimulates natural growth hormone release to aid recovery and body composition.
Supports fat metabolism without affecting blood sugar.
Reduces visceral fat and supports metabolic health.
Promotes healing and recovery of tissues and joints.
Supports cellular energy production and longevity.
Enhances cognitive function and mental clarity.
Improves focus and reduces anxiety.
Stimulates fat breakdown and supports weight management.
Accelerates wound healing and tissue repair.
Enhances sexual desire and arousal through central nervous system activation.
Promotes skin health and collagen production.
Supports brain health and cognitive performance.
AOD-9604 is the C-terminal fragment of human growth hormone (hGH 177-191) with an additional tyrosine residue. It mimics the fat-burning action of HGH by stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat storage) in adipose tissue. Crucially, it does this without affecting blood sugar levels, IGF-1 production, or triggering cellular proliferation — making it a targeted metabolic agent without the systemic effects of full-length growth hormone.
AOD-9604 has been studied in multiple human clinical trials. A Phase IIb trial involving over 300 obese subjects demonstrated statistically significant weight loss compared to placebo over 12 weeks. The compound received GRAS (Generally Recognized As Safe) designation from the FDA, confirming its favorable safety profile. Studies show it does not affect IGF-1 levels, glucose tolerance, or growth markers — confirming its targeted mechanism of action.
Stimulates fat breakdown and inhibits fat storage without systemic growth hormone effects.
Does not affect glucose metabolism or insulin sensitivity, unlike full-length HGH.

Isolated fat-burning mechanism without IGF-1 elevation or cellular proliferation.
Received GRAS (Generally Recognized As Safe) status from the FDA for food applications.
AOD-9604 is administered as a subcutaneous injection, typically once daily in the morning on an empty stomach. Some protocols also include oral formulations. Your provider will determine the optimal dosing and route based on your weight management goals.
All dosing is determined by your licensed provider based on your individual health profile. Do not self-administer without medical supervision.
Every peptide we offer is backed by peer-reviewed research and clinical data. Our medical team stays current with the latest findings to ensure your protocol reflects the best available science.
Your medications arrive in unmarked, temperature-controlled packaging shipped directly from licensed compounding pharmacies. Privacy and quality guaranteed at every step.
Every treatment is prescribed and monitored by a licensed physician. Regular check-ins, lab reviews, and dosage adjustments ensure your peptide therapy is safe and effective throughout your journey.
Savings apply when multiple peptides are prescribed.
| BUNDLE SIZE | INCLUDED | SAVINGS |
|---|---|---|
| 2 Peptides | Simple paired therapy | SAVE 20• |
| 3 Peptides | Multi-pathway plan | SAVE 30• |
| 4 Peptides | Full personalized set | BEST VALUE |
•• Results vary. Prescribed only when clinically appropriate.
Includes doctor review & treatment plan

Includes doctor review & treatment plan

Includes doctor review & treatment plan

Includes doctor review & treatment plan

All plans include a doctor review, personalized treatment plan (if approved), and 24/7 access to a licensed provider in your state.
No. AOD-9604 is a small fragment of the growth hormone molecule (amino acids 177-191) that only replicates the fat-burning effects of HGH. It does not have growth-promoting, blood sugar, or IGF-1 effects.
No. Clinical studies have confirmed that AOD-9604 does not affect glucose metabolism or insulin sensitivity, making it distinct from full-length growth hormone.
Weight management results with AOD-9604 typically become apparent over 8-12 weeks of consistent use, combined with appropriate diet and exercise. Early changes in body composition may be noticed sooner.
Yes, AOD-9604 and GLP-1 therapy target weight management through different mechanisms and can be complementary under physician guidance. Your provider will design the optimal combination protocol.
AOD-9604 has received FDA GRAS designation and has demonstrated a favorable safety profile in clinical trials. Long-term use should be supervised by your provider with regular monitoring.
Quick online assessment

Licensed provider reviews your medical history

Medication shipped directly once approved

Ongoing support and check-ins

Secure telehealth · GDPR-compliant · Pharmacy-grade compounding.
Not for self-administration. Reviewed by a medical provider.
Clinically studied peptides designed to target metabolism, recovery, energy, and longevity.
Learn more →The mitochondrial peptide for metabolic health and cellular energy.
Learn more →FDA-studied GHRH analog for visceral fat reduction and metabolic health.
Learn more →Doctor-guided peptide treatments personalized to your health goals. Start with a free consultation.
Starting at
Includes doctor review & 24/7 provider access
All plans include doctor review, treatment plan, and 24/7 provider access.